BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17532621)

  • 1. Clinical implications of steroid receptor coactivator (SRC)-3 in uterine endometrial cancers.
    Sakaguchi H; Fujimoto J; Sun WS; Tamaya T
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):237-40. PubMed ID: 17532621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: Correlation with clinicopathologic parameters and biomarkers.
    Balmer NN; Richer JK; Spoelstra NS; Torkko KC; Lyle PL; Singh M
    Mod Pathol; 2006 Dec; 19(12):1593-605. PubMed ID: 16980945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SRC-3 is required for prostate cancer cell proliferation and survival.
    Zhou HJ; Yan J; Luo W; Ayala G; Lin SH; Erdem H; Ittmann M; Tsai SY; Tsai MJ
    Cancer Res; 2005 Sep; 65(17):7976-83. PubMed ID: 16140970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of steroid receptor coactivators and corepressors in human endometrial hyperplasia and carcinoma with relevance to steroid receptors and Ki-67 expression.
    Uchikawa J; Shiozawa T; Shih HC; Miyamoto T; Feng YZ; Kashima H; Oka K; Konishi I
    Cancer; 2003 Nov; 98(10):2207-13. PubMed ID: 14601091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The p160 steroid receptor coactivator 2, SRC-2, regulates murine endometrial function and regulates progesterone-independent and -dependent gene expression.
    Jeong JW; Lee KY; Han SJ; Aronow BJ; Lydon JP; O'Malley BW; DeMayo FJ
    Endocrinology; 2007 Sep; 148(9):4238-50. PubMed ID: 17556502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development.
    Xu J; Liao L; Ning G; Yoshida-Komiya H; Deng C; O'Malley BW
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6379-84. PubMed ID: 10823921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of estrogen receptor coregulators in normal and malignant human endometrium.
    Kershah SM; Desouki MM; Koterba KL; Rowan BG
    Gynecol Oncol; 2004 Jan; 92(1):304-13. PubMed ID: 14751175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SRC-3/AIB1: transcriptional coactivator in oncogenesis.
    Yan J; Tsai SY; Tsai MJ
    Acta Pharmacol Sin; 2006 Apr; 27(4):387-94. PubMed ID: 16539836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of SRC-3 intercompartmental dynamics by estrogen receptor and phosphorylation.
    Amazit L; Pasini L; Szafran AT; Berno V; Wu RC; Mielke M; Jones ED; Mancini MG; Hinojos CA; O'Malley BW; Mancini MA
    Mol Cell Biol; 2007 Oct; 27(19):6913-32. PubMed ID: 17646391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implication of estrogen-related receptor (ERR) expression in uterine endometrial cancers.
    Fujimoto J; Sato E
    J Steroid Biochem Mol Biol; 2009 Aug; 116(1-2):71-5. PubMed ID: 19416752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SRC-3/AIB1 protein and gene amplification levels in human esophageal squamous cell carcinomas.
    Xu FP; Xie D; Wen JM; Wu HX; Liu YD; Bi J; Lv ZL; Zeng YX; Guan XY
    Cancer Lett; 2007 Jan; 245(1-2):69-74. PubMed ID: 16458427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.
    Devis L; Moiola CP; Masia N; Martinez-Garcia E; Santacana M; Stirbat TV; Brochard-Wyart F; García Á; Alameda F; Cabrera S; Palacios J; Moreno-Bueno G; Abal M; Thomas W; Dufour S; Matias-Guiu X; Santamaria A; Reventos J; Gil-Moreno A; Colas E
    J Pathol; 2017 Mar; 241(4):475-487. PubMed ID: 27873306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of steroid receptor coactivators in cultured cells from paired myometrial and fibroid tissues.
    Hussein-Fikret S; Fuller PJ; Gargett CE
    J Soc Gynecol Investig; 2005 Sep; 12(6):445-51. PubMed ID: 15979354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance and clinical importance of estrogen receptor alpha and beta in human endometrioid adenocarcinomas.
    Mylonas I
    Oncol Rep; 2010 Aug; 24(2):385-93. PubMed ID: 20596625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway.
    Yan J; Yu CT; Ozen M; Ittmann M; Tsai SY; Tsai MJ
    Cancer Res; 2006 Nov; 66(22):11039-46. PubMed ID: 17108143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of microRNA-200c expression levels with clinicopathological factors and prognosis in endometrioid endometrial cancer.
    Wilczynski M; Danielska J; Domanska-Senderowska D; Dzieniecka M; Szymanska B; Malinowski A
    Acta Obstet Gynecol Scand; 2018 May; 97(5):560-569. PubMed ID: 29355888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular structure and biological function of the cancer-amplified nuclear receptor coactivator SRC-3/AIB1.
    Liao L; Kuang SQ; Yuan Y; Gonzalez SM; O'Malley BW; Xu J
    J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):3-14. PubMed ID: 12650696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oestrogen receptor beta expression and depth of myometrial invasion in human endometrial cancer.
    Takama F; Kanuma T; Wang D; Kagami I; Mizunuma H
    Br J Cancer; 2001 Feb; 84(4):545-9. PubMed ID: 11207052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genomic analysis of the impact of steroid receptor coactivators ablation on hepatic metabolism.
    Jeong JW; Kwak I; Lee KY; White LD; Wang XP; Brunicardi FC; O'Malley BW; DeMayo FJ
    Mol Endocrinol; 2006 May; 20(5):1138-52. PubMed ID: 16423883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta signaling is disrupted in endometrioid-type endometrial carcinomas.
    Piestrzeniewicz-Ulanska D; Brys M; Semczuk A; Rechberger T; Jakowicki JA; Krajewska WM
    Gynecol Oncol; 2004 Oct; 95(1):173-80. PubMed ID: 15385128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.